Terms: = Gastric cancer AND PIM1, PIM, 5292, ENSG00000137193, P11309
31 results:
1. Subcellular localization of nucleolar protein 14 and its proliferative function mediated by miR-17-5p and E2F4 in pancreatic cancer.
Du YX; Zhou Y; Zheng XH; Duan YJ; Gu ZT; Yin YF; Wang CF
Aging (Albany NY); 2023 Jul; 15(14):7308-7323. PubMed ID: 37506248
[TBL] [Abstract] [Full Text] [Related]
2. CBF-Beta Mitigates PI3K-Alpha-Specific Inhibitor Killing through pim1 in PIK3CA-Mutant gastric cancer.
Stanland LJ; Ang HX; Hoj JP; Chu Y; Tan P; Wood KC; Luftig MA
Mol Cancer Res; 2023 Nov; 21(11):1148-1162. PubMed ID: 37493631
[TBL] [Abstract] [Full Text] [Related]
3. Discovery of small molecule acting as multitarget inhibitor of colorectal cancer by simultaneous blocking of the key COX-2, 5-LOX and pim-1 kinase enzymes.
El-Miligy MMM; Al-Kubeisi AK; El-Zemity SR; Nassra RA; Abu-Serie MM; Hazzaa AA
Bioorg Chem; 2021 Oct; 115():105171. PubMed ID: 34303896
[TBL] [Abstract] [Full Text] [Related]
4. Synthesis of Heterocyclic Compounds Derived From Dimedone and their Anti-tumor and Tyrosine Kinase Inhibitions.
Mohareb RM; Manhi FM; Abdelwahab A
Acta Chim Slov; 2020 Mar; 67(1):83-95. PubMed ID: 33558929
[TBL] [Abstract] [Full Text] [Related]
5. Resveratrol suppresses gastric cancer cell proliferation and survival through inhibition of pim-1 kinase activity.
Kim S; Kim W; Kim DH; Jang JH; Kim SJ; Park SA; Hahn H; Han BW; Na HK; Chun KS; Choi BY; Surh YJ
Arch Biochem Biophys; 2020 Aug; 689():108413. PubMed ID: 32473133
[TBL] [Abstract] [Full Text] [Related]
6. Synthesis and Anti-Proliferative Evaluations of New Heterocyclic Derivatives Using 5,6,8,9-Tetrahydropyrazolo[5,1-b]quinazolin-7(3H)-one Derivatives Derived from Cyclohexa-1,4-dione.
Mahmoud MAA; Alsharif MA; Mohareb RM
Anticancer Agents Med Chem; 2021; 21(4):468-486. PubMed ID: 32445457
[TBL] [Abstract] [Full Text] [Related]
7. MicroRNA-101-3p regulates gastric cancer cell proliferation, invasion and apoptosis by targeting pim 1 expression.
Wu F; Huang W; Yang L; Xu F
Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):118-122. PubMed ID: 31880528
[TBL] [Abstract] [Full Text] [Related]
8. Novel endoscopic findings as visualized by non-magnification endoscopy with linked color imaging are indicative of gastric intestinal metaplasia.
Min M; Dong TH; Liu Y; Bi YL; Ma CY
Chin Med J (Engl); 2019 Apr; 132(7):782-788. PubMed ID: 30896610
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of Monitor-Image and Printout-Image Methods in Ki-67 Scoring of Gastroenteropancreatic Neuroendocrine Tumors.
Dogukan FM; Yilmaz Ozguven B; Dogukan R; Kabukcuoglu F
Endocr Pathol; 2019 Mar; 30(1):17-23. PubMed ID: 30367334
[TBL] [Abstract] [Full Text] [Related]
10. Pan-pim Kinase Inhibitor AZD1208 Suppresses Tumor Growth and Synergistically Interacts with Akt Inhibition in gastric cancer Cells.
Lee M; Lee KH; Min A; Kim J; Kim S; Jang H; Lim JM; Kim SH; Ha DH; Jeong WJ; Suh KJ; Yang YW; Kim TY; Oh DY; Bang YJ; Im SA
Cancer Res Treat; 2019 Apr; 51(2):451-463. PubMed ID: 29879757
[TBL] [Abstract] [Full Text] [Related]
11. pim1 supports human colorectal cancer growth during glucose deprivation by enhancing the Warburg effect.
Zhang M; Liu T; Sun H; Weng W; Zhang Q; Liu C; Han Y; Sheng W
Cancer Sci; 2018 May; 109(5):1468-1479. PubMed ID: 29516572
[TBL] [Abstract] [Full Text] [Related]
12. MiR-144 functions as tumor suppressor by targeting pim1 in gastric cancer.
Ren K; Liu QQ; An ZF; Zhang DP; Chen XH
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3028-3037. PubMed ID: 28742204
[TBL] [Abstract] [Full Text] [Related]
13. Activation of pim Kinases Is Sufficient to Promote Resistance to MET Small-Molecule Inhibitors.
An N; Xiong Y; LaRue AC; Kraft AS; Cen B
Cancer Res; 2015 Dec; 75(24):5318-28. PubMed ID: 26670562
[TBL] [Abstract] [Full Text] [Related]
14. Downregulation of microRNA‑33a promotes cyclin‑dependent kinase 6, cyclin D1 and pim1 expression and gastric cancer cell proliferation.
Wang Y; Zhou X; Shan B; Han J; Wang F; Fan X; Lv Y; Chang L; Liu W
Mol Med Rep; 2015 Nov; 12(5):6491-500. PubMed ID: 26352175
[TBL] [Abstract] [Full Text] [Related]
15. Comparison of Gene Expression Between Pediatric and Adult gastric Mucosa with Helicobacter pylori Infection.
Obayashi N; Ohtsuka Y; Hosoi K; Ikuse T; Jimbo K; Aoyagi Y; Fujii T; Kudo T; Asaoka D; Hojo M; Nagahara A; Watanabe S; Shimizu T
Helicobacter; 2016 Apr; 21(2):114-23. PubMed ID: 26140656
[TBL] [Abstract] [Full Text] [Related]
16. Kaempferol enhances the suppressive function of Treg cells by inhibiting FOXP3 phosphorylation.
Lin F; Luo X; Tsun A; Li Z; Li D; Li B
Int Immunopharmacol; 2015 Oct; 28(2):859-65. PubMed ID: 25870037
[TBL] [Abstract] [Full Text] [Related]
17. A small-molecule inhibitor of pim kinases as a potential treatment for urothelial carcinomas.
Foulks JM; Carpenter KJ; Luo B; Xu Y; Senina A; Nix R; Chan A; Clifford A; Wilkes M; Vollmer D; Brenning B; Merx S; Lai S; McCullar MV; Ho KK; Albertson DJ; Call LT; Bearss JJ; Tripp S; Liu T; Stephens BJ; Mollard A; Warner SL; Bearss DJ; Kanner SB
Neoplasia; 2014 May; 16(5):403-12. PubMed ID: 24953177
[TBL] [Abstract] [Full Text] [Related]
18. Differential expression of pim-3, c-Myc, and p-p27 proteins in adenocarcinomas of the gastric cardia and distal stomach.
Lou L; Wang Y; Cui J; Yan X; Xue L; Li Y
Tumour Biol; 2014 May; 35(5):5029-36. PubMed ID: 24488669
[TBL] [Abstract] [Full Text] [Related]
19. T-18, a stemonamide synthetic intermediate inhibits pim kinase activity and induces cell apoptosis, acting as a potent anticancer drug.
Wang Z; Li XM; Shang K; Zhang P; Wang CF; Xin YH; Zhou L; Li YY
Oncol Rep; 2013 Mar; 29(3):1245-51. PubMed ID: 23314349
[TBL] [Abstract] [Full Text] [Related]
20. Clinical and therapeutic relevance of pim1 kinase in gastric cancer.
Yan B; Yau EX; Samanta S; Ong CW; Yong KJ; Ng LK; Bhattacharya B; Lim KH; Soong R; Yeoh KG; Deng N; Tan P; Lam Y; Salto-Tellez M;
Gastric Cancer; 2012 Apr; 15(2):188-97. PubMed ID: 21993851
[TBL] [Abstract] [Full Text] [Related]
[Next]
